Medicare FFS ophthalmology
Provider service volume comparison
Compare two ophthalmology providers by CY2023 Medicare FFS service volume and CPT/HCPCS mix.
Robert J Olk, MD
NPI 1265429245 | Saint Louis, MO
- National rank
- #5
- Total services
- 332,905
Choose provider
No provider selected.
Search providersCPT/HCPCS service volume comparison
Rows compare visible public provider-service lines by Medicare FFS service count.
| CPT/HCPCS | Description | Provider A services | Provider B services | Absolute difference | Higher Medicare FFS service volume |
|---|---|---|---|---|---|
| J2403 | Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | 301,600 | 0 | 301,600 | Provider A higher |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 16,500 | 0 | 16,500 | Provider A higher |
| J3396 | Injection, verteporfin, 0.1 mg | 7,650 | 0 | 7,650 | Provider A higher |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 1,125 | 0 | 1,125 | Provider A higher |
| 92134 | Imaging of retina | 1,010 | 0 | 1,010 | Provider A higher |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 930 | 0 | 930 | Provider A higher |
| 67028 | Injection of drug into eye | 675 | 0 | 675 | Provider A higher |
| J3299 | Injection, triamcinolone acetonide (xipere), 1 mg | 540 | 0 | 540 | Provider A higher |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 411 | 0 | 411 | Provider A higher |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 255 | 0 | 255 | Provider A higher |
| J3490 | Unclassified drugs | 164 | 0 | 164 | Provider A higher |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 143 | 0 | 143 | Provider A higher |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 133 | 0 | 133 | Provider A higher |
| 92250 | Photography of the retina | 119 | 0 | 119 | Provider A higher |
| J9035 | Injection, bevacizumab, 10 mg | 117 | 0 | 117 | Provider A higher |
| 92242 | Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye | 99 | 0 | 99 | Provider A higher |
| 92283 | Extended exam involving color vision testing | 87 | 0 | 87 | Provider A higher |
| 92273 | Measurement of retinal and optic nerve function | 85 | 0 | 85 | Provider A higher |
| 67515 | Injection of drug or substance into membrane covering eyeball | 81 | 0 | 81 | Provider A higher |
| 92020 | Exam of the internal drainage system of eye | 80 | 0 | 80 | Provider A higher |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 71 | 0 | 71 | Provider A higher |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 70 | 0 | 70 | Provider A higher |
| J3590 | Unclassified biologics | 62 | 0 | 62 | Provider A higher |
| J0178 | Injection, aflibercept, 1 mg | 52 | 0 | 52 | Provider A higher |
| 67221 | Destruction of vascular growth between retina and sclera by photodynamic therapy | 51 | 0 | 51 | Provider A higher |
| 76512 | 2d ultrasound scan of eye tissue and structures | 48 | 0 | 48 | Provider A higher |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 47 | 0 | 47 | Provider A higher |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | 42 | 0 | 42 | Provider A higher |
| 67040 | Destruction of eye fluid (vitreous) between lens and retina and all of retina using a laser | 34 | 0 | 34 | Provider A higher |
| J1020 | Injection, methylprednisolone acetate, 20 mg | 30 | 0 | 30 | Provider A higher |
| 66821 | Removal of recurring cataract in lens capsule using a laser | 26 | 0 | 26 | Provider A higher |
| 67113 | Complex repair of detached retina and drainage of eye fluid between lens and retina | 26 | 0 | 26 | Provider A higher |
| 92082 | Exam of visual field with intermediate testing | 26 | 0 | 26 | Provider A higher |
| 65800 | Removal of eye fluid | 23 | 0 | 23 | Provider A higher |
| 67225 | Destruction of vascular growth between retina and sclera by photodynamic therapy for second eye at 1 session | 21 | 0 | 21 | Provider A higher |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | 21 | 0 | 21 | Provider A higher |
| 67210 | Destruction of growth of retina using a laser | 17 | 0 | 17 | Provider A higher |
| 0465T | Injection of medication into space above choroid membrane of eye | 15 | 0 | 15 | Provider A higher |
| 76519 | Ultrasound scan to determine eye length and lens power | 14 | 0 | 14 | Provider A higher |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | 13 | 0 | 13 | Provider A higher |
| 92274 | Measurement of retinal and optic nerve function targeting multiple separate locations | 12 | 0 | 12 | Provider A higher |